ESC 365 - Conclusion - Innovation in arrhythmia management enabling durable therapeutic benefits.

ESC Premium Access

Conclusion - Innovation in arrhythmia management enabling durable therapeutic benefits.

Session: Innovation in arrhythmia management enabling durable therapeutic benefits

Topic: Automatic implantable cardioverter / defibrillator

Speaker: Doctor F. Arribas (Madrid, ES)

Sponsored by Boston Scientific

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Fernando Arribas

12th of October University Hospital, Madrid (Spain)

11 presentations

2 followers

4 more presentations in this session

Introduction - Innovation in arrhythmia management enabling durable therapeutic benefits.

Speaker: Doctor G. Botto (Garbagnate Milanese, IT)

Prolonged device longevity for prolonged patient life expectancy.

Speaker: Doctor E. Lau (Belfast, GB)

ESC Guidelines and patient selection for the subcutaneous implantable defibrillator.

Speaker: Professor S. Boveda (Toulouse, FR)

Opportunities by introducing high resolution mapping and ablation into daily practice.

Speaker: Assistant Professor H. Estner (Munich, DE)

Access the full session

Innovation in arrhythmia management enabling durable therapeutic benefits

Speakers: Doctor F. Arribas, Doctor G. Botto, Doctor E. Lau, Professor S. Boveda, Assistant Professor H. Estner

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources